Product
First of its kind patient cohort program announced at IPF-Summit
August 29th, 2022
NEW YORK, August 29, 2022 — A first-of-its-kind patient cohort platform will soon be available to UK and US researchers struggling to recruit patients with interstitial lung disease (ILD), such as pulmonary fibrosis and progressing fibrosis resulting from COVID-19. UK-based company uMed announced the launch of the Access-ILD/PF Cohort at the sixth annual Idiopathic Pulmonary…
